FiercePharma

SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available in the United States

SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...
The Financial

Adding SPIRIVA Respimat Effective for Uncontrolled Asthma – Regardless of Allergy Subtype

The FINANCIAL — Boehringer Ingelheim on March 8 announced the presentation of new post-hoc analyses that show the addition of SPIRIVA (tiotropium) Respimat to other asthma maintenance therapies helps ...
News Medical

Spiriva Respimat (with dose indicator)

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Spiriva Respimat contains the active ingredient tiotropium. Spiriva ...
FiercePharma

FDA Approves Boehringer Ingelheim's SPIRIVA RESPIMAT for the Maintenance Treatment of Asthma in Adults and Adolescents

RIDGEFIELD, Conn., September 16, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA RESPIMAT for the long-term, ...
FierceBiotech

FDA Advisory Committee Recommends Approval of Tiotropium Respimat® for the Maintenance Treatment of COPD

RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee ...
Business Insider

FDA Approves Stiolto® Respimat® Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction

RIDGEFIELD, Conn., Oct. 11, 2018 /PRNewswire/ -- Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) approved new labeling for Stiolto Respimat (tiotropium bromide & ...
The American Journal of Managed Care

Head-to-Head Study Results About Two COPD Inhalers Gives One an Edge

A study of 2 chronic obstructive pulmonary disease (COPD) inhalers from the same company was published recently in The Lancet Respiratory Medicine. The DYNAGITO trial showed tiotropium bromide and ...
FierceBiotech

Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD

RIDGEFIELD, Conn., August 19, 2014 – Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for the fixed-dose ...
Business Wire

Global Spiriva (Tiotropium; Boehringer Ingelheim) Market Analysis & Forecast 2017-2026 with Sales Revenue by Country - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spiriva" report has been added to ResearchAndMarkets.com's offering. Spiriva (tiotropium; Boehringer Ingelheim) is a long-acting muscarinic antagonist (LAMA) approved for ...
Monthly Prescribing Reference

Stiolto Respimat Labeling Updated With COPD Exacerbation Data, Revised Indication

In addition to the new exacerbation data, the indication for Stiolto Respimat has been revised. The Food and Drug Administration (FDA) has approved updated labeling for Stiolto Respimat (tiotropium ...
Monthly Prescribing Reference

Spiriva Handihaler

Tiotropium (as bromide monohydrate) 18mcg/cap; dry pwd in caps for oral inhalation; with inhaler device. Spiriva Handihaler consists of Spiriva capsules and the Handihaler device. Spiriva capsules ...